●End of enrollment for the ulcerative colitis trial
●Initiation of the GvHD phase II/III trial
●Initiation of the acute myocardial infarction phase II trial
●Realization of a partnership for the obesity drug
●Realization of a partnership for ischemic stroke
●Future grants or awards
●Potential milestone payments from RTI or Pfizer
●Legislation for Regenerative Medicine in Japan, may bring fast development path news.
★ UC trial results\data release ★ IS trial results\data release
✔ Existing investor asked them if they could buy more shares. This is an institutional size investor. They do homework!!!! Think about it $20 million!!! (how often do you see this?)
Acute myocardial infarction phase II trial - may have two catalysts: Initiation as listed above and a partnering per the webcast today.
Also "aggressively going after Japan" per webcast today 12/4/2013